On ECHEMI
Home > Drugs > Pachydermatous periostitis
Pachydermatous periostitis
Pachyermoperiostosis is also known as hypertrophic skin periosteal bone hyperplasia and Touraine-Solente-Gole syndrome. The primary form may be autosomal dominant, and the secondary form is also called hyperproliferative osteoarthropathy. It is often secondary to various chronic and malignant tumor diseases, and the pathogenesis is still unclear. Primary pachyermoperiostosis is mainly seen in men, which may be an autosomal dominant genetic disease with different penetrances. Such cases have been reported in China. Secondary pachyermoperiostosis may also be a genetic disease, but it is often stimulated by severe liver disease, bronchial lung cancer or epithelial adenocarcinoma, bronchiectasis, lung abscess, or gastric cancer, esophageal cancer, thymic cancer, etc.
  • Site of disease:

    Skin Bone
  • Infectious :

    Not contagious
  • Frequent population:

    Primary: male; Secondary: middle-aged female...
  • Related symptoms:

    Skin hypertrophy Joint effusion Deepening of forehead lines Thickening and loosening of upper eyelids Diffuse periosteal thickening
  • Concurrent disease:

Related Drugs
Children's compound four-dimensional iron powder
Indication: Used to promote bone development in infants and young children, improve anemia and as an auxiliary treatment for calcium deficiency in infants and young children.
Manufacturer:

Hunan Warrant Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.